| Drug Name |
Eletriptan |
| Drug ID |
BADD_D00755 |
| Description |
Eletriptan is a second generation triptan drug developed by Pfizer Inc for the treatment of migraine headaches. |
| Indications and Usage |
For the acute treatment of migraine with or without aura in adults. |
| Marketing Status |
approved; investigational |
| ATC Code |
N02CC06 |
| DrugBank ID |
DB00216
|
| KEGG ID |
D07887
|
| MeSH ID |
C115647
|
| PubChem ID |
77993
|
| TTD Drug ID |
D02DMQ
|
| NDC Product Code |
Not Available |
| UNII |
22QOO9B8KI
|
| Synonyms |
eletriptan | (R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole | UK 166,044 | UK-166044 | UK 166044 | UK-166,044 | Relpax | UK-116044-04 | UK-116,044-04 | eletriptan hydrobromide | (R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole monohydrobromide | 3-(1-methyl-2-pyrrolidinylmethyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole hydrobromide |
